Skip to main content
. Author manuscript; available in PMC: 2018 Apr 11.
Published in final edited form as: Neuroscience. 2015 Jan 28;290:115–125. doi: 10.1016/j.neuroscience.2015.01.034

Table 2.

Cytokines in the upper spinal cord not significantly increased compared to control levels in response to systemic nicotine

Cytokine Fold change ± SEM P
CINC-1 0.94 ± 0.17 0.818
CINC-2α 1.56 ± 0.30 0.310
CINC-3 1.42 ± 0.15 0.240
CNTF 0.90 ± 0.23 0.589
Fractalkine 1.10 ± 0.11 0.485
GM-CSF 1.56 ± 0.15 0.065
sICAM-1 1.27 ± 0.07 0.394
IFN-γ 1.30 ± 0.13 0.180
IL-1α 1.31 ± 0.13 0.240
IL-1β 1.24 ± 0.17 0.394
IL-1rα 1.34 ± 0.18 0.132
IL-3 1.52 ± 0.23 0.132
IL-10 1.41 ± 0.30 0.310
IL-13 1.32 ± 0.08 0.132
RANTES 1.21 ± 0.07 0.065
Thymus chemokine 0.97 ± 0.02 0.240
TIMP-1 1.92 ± 0.44 0.180

CINC-1=cytokine-induced neutrophil chemoattractant 1, CINC-2α=cytokine-induced neutrophil chemoattractant 2 alpha, CINC3=cytokine-induced neutrophil chemoattractant 3, CNTF=ciliary neurotrophic factor, Fractalkine, GM-CSF= granulocyte macrophage-colony stimulating factor, sICAM-1=intercellular Adhesion Molecule 1, IFN-γ=interferon gamma, IL-1α=interleukin 1 alpha, IL-1β=interleukin 1 beta, IL-1rα=interleukin 1 receptor antagonist, IL-3= interleukin 3, IL-10=interleukin 10, IL-13=interleukin 13, RANTS=regulated on activation, normal T cell expressed and secreted, TIMP-1=tissue inhibitor of metalloproteinase 1.